First human test of surgical 'Bandage' to fight returning cancer
NCT ID NCT04619056
Summary
This first-in-human study tested the safety of a special drug-coated membrane placed in the surgical area after tumor removal for aggressive or returning abdominal soft tissue sarcoma. The goal was to see if delivering chemotherapy directly to the surgery site was safe and tolerable, with the hope of controlling local cancer recurrence. The study involved 21 patients and carefully increased the drug dose to find the safest level for future testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fundación Jiménez Díaz
Madrid, 28040, Spain
-
Hospital General Universitario Gregorio Marañón
Madrid, 28007, Spain
-
Hospital Universitario Vall d'Hebron
Barcelona, 08035, Spain
-
Hospital Universitario y Politécnico La Fe
Valencia, 46026, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, Catalonia, 08041, Spain
Conditions
Explore the condition pages connected to this study.